KRAS and cancer: To understand this observation further, we analyzed data from The Cancer Genome Atlas (TCGA) Pan-Cancer Atlas, which verified a significant co-occurrence of KRAS and PIK3CA mutations in CRC (Supplemental Figure 6B).